In this role, you will be responsible to develops and maintains effective relationships through effective and timely communication. Responsible for driving the fms culture through values and customer service standards.
As a clinical supervisor of our hemodialysis team, the natural leader we select will provide direction, inspiration, and counseling to staff members, and coordinate all aspects of care, from admission to discharge. In addition, this individual will hire, train, lead a team, and ensure quality control and compliance with laws and regulations.
In this role, you will be responsible for operational aspects of one or more clinical trials (phase I-IV, Expanded Access, Investigator Initiated, registries and Compassionate Use) under the leadership of the CTH.
The Manager, Clinical Quality Assessment (CQA) Auditor is responsible for the initiation, conduct, and follow-up of audits as assigned by CQA Management. Within the frame of the Manager, CQA Auditors mission and responsibilities, the audits and activities require proven ability to independently interact with all internal (e.g. Projects Teams, Trial Operations) and external (e.g. Vendors / CRO) operational staff involved in the audited clinical research activities.
To help you find the most relevant
jobs, we've come up with an approximate compensation for this
position. This is based on similar jobs with compensation
$60K to $80K -Manhattan, NY
In this role, you will manage the day-to-day intake operations from all referral sources. Works collaboratively with Operations and referrers to assure a safe transition to home care. Assists the department in meeting agency goals. Works under general direction.
In this role, you will develop and/or oversee development of other project-related documents including protocols, case report forms, study manuals, informed consent forms, monitoring plans, communication plans, tracking tools, and other project tools as needed.
The Local Study Manager is responsible for planning, executing and reporting on a number of phase II-III and global phase IV clinical studies for the planning and site feasibility through study close-out, in compliance with Novartis processes and regulatory requirements.